NBOMes

General Information

Classification: Psychedelic (with reported stimulating properties)

History

These chemicals have nearly no history of human use prior to 2010 when they first became available online.

The NBOMe family of chemicals is relatively new and very little is known about this group of compounds. These chemicals may only be used with extreme caution.

25i-NBOMe Dosage

Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect).

Oral

Duration: 4-14 hours

Low dose: 200-500 ug (micrograms!)

Medium (typical) dose: 500-1500 ug (micrograms!)

High dose: >1500 ug (micrograms!)

Insufflated

Duration: 3-8 hours

Onset: 0-10 minutes

Low dose: 100 - 400 ug (micrograms!)

Medium (typical) dose: 400 - 700 ug (micrograms!)

High dose: >700 ug (micrograms!)

25c-NBOMe Dosage

Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect).

Oral

Duration: 4-11 hours

Low dose: X ug (micrograms!)

Medium (typical) dose: X ug (micrograms!)

High dose: X ug (micrograms!)

Insufflated

Duration: 3-8 hours

Onset: 0-10 minutes

Low dose: 100-300 ug (micrograms!)

Medium (typical) dose: 300-500 ug (micrograms!)

High dose: >500 ug (micrograms!)

Effects

After effects

• "Hangover"?

• Afterglow

• Long term effects

Harm Reduction

• Avoid driving and operating heavy machinery

Do not attempt to operate heavy machinery, drive, ride a bike or do anything similar. Delayed reaction time and altering of your visual perception make these kind of activities unsafe.

• Recommended time (pauses) between using the substance

>2 weeks for a 100% tolerance reset, but the more time the better. You have only one body, be careful with it.

• Addiction potential?

So far no reports of addiction have surfaced.

• Risk of death?

Most reports of death by an NBOMe chemical involve mislabeling of the drug (for example: someone insufflates 20mg of 25i-NBOMe because he/she thought it was 2C-I). This chemical is extremely potent and has a relatively low LD50 (LD50 is the dosage at which 50% of the tested population does not survive). Therefore, a mislabeling can result in death.

• Mental illness?

Do not use when you have a history of mental illness or a family history of mental illness (such as depression, schizophrenia, psychosis, bipolar disorder, etc.)

• Heart issues?

Do not use when you have a history of heart issues or a family history of heart issues.

Images

• 

  italic caption

• 
• 
• 
• 

Legal

Europe

The -NBOMe series of psychoactives became controlled in the Russian Federation starting October, 2011. See http://www.rg.ru/2011/10/19/narko-dok.html

America

The NBOMe series of compounds are unscheduled in the United States. It is possible that some of them would be considered analogs (of scheduled phenethylamines such as 2C-B or mescaline), in which case, sales for human consumption or possession with the intent to ingest could be prosecuted under the Federal Analogue Act. However, Virginia has recently made the 25x-NBOMe series and all its analogues schedule I; expected is that more states are to follow quickly.